APELY vs. VPG: Which Stock Is the Better Value Option? — Neutral
APELY VPG Zacks Investment Research — January 16, 2026Investors looking for stocks in the Electronics - Miscellaneous Components sector might want to consider either Alps Electric (APELY) or Vishay Precision (VPG). But which of these two stocks is more attractive to value investors?
APEI vs. UTI: Which Stock Should Value Investors Buy Now? — Positive
APEI UTI Zacks Investment Research — January 16, 2026Investors looking for stocks in the Schools sector might want to consider either American Public Education (APEI) or Universal Technical Institute (UTI). But which of these two companies is the best option for those looking for undervalued stocks?
AER vs. WAB: Which Stock Is the Better Value Option? — Positive
AER WAB Zacks Investment Research — January 16, 2026Investors looking for stocks in the Transportation - Equipment and Leasing sector might want to consider either AerCap (AER) or Westinghouse Air Brake Technologies (WAB). But which of these two companies is the best option for those looking for undervalued stocks?
PECO vs. SKT: Which Stock Should Value Investors Buy Now? — Positive
PECO SKT Zacks Investment Research — January 16, 2026Investors looking for stocks in the REIT and Equity Trust - Retail sector might want to consider either Phillips Edison & Company, Inc. (PECO) or Tanger (SKT). But which of these two stocks offers value investors a better bang for their buck right now?
TGS or WMB: Which Is the Better Value Stock Right Now? — Positive
TGS WMB Zacks Investment Research — January 16, 2026Investors with an interest in Oil and Gas - Production and Pipelines stocks have likely encountered both Transportadora De Gas Sa Ord B (TGS) and Williams Companies, Inc. (The) (WMB). But which of these two stocks is more attractive to value investors?
CWENA vs. ORA: Which Stock Is the Better Value Option? — Positive
ORA Zacks Investment Research — January 16, 2026Investors with an interest in Alternative Energy - Other stocks have likely encountered both Clearway Energy (CWENA) and Ormat Technologies (ORA). But which of these two stocks is more attractive to value investors?
3 Low P/E Stocks: Separating Multibaggers From a Value Trap — Negative
CMCSA HPQ RCI MarketBeat — January 16, 2026P/E, the price-to-earnings multiple, is a measure of stock value relative to earnings power and a cornerstone of value investing. Stocks with lower price multiples are cheaper to own relative to their earnings power, indicate value for investors, and have the potential for significant price gains over time.
Why Should Investors Keep PLPC Stock in Their Portfolio Now? — Positive
PLPC Zacks Investment Research — January 16, 2026Preformed Line Products' strong revenue growth, solid balance sheet and global reach support its place as a steady long-term portfolio holding.
Navigating the Now and Next: ManpowerGroup Advances Action Around AI and Workforce Readiness at the World Economic Forum Annual Meeting in Davos — Neutral
MAN PRNewsWire — January 16, 2026Bringing the Human Edge to AI Transformation, the global workforce leader joins world leaders to advance practical solutions and close the skills gap. MILWAUKEE, Jan. 16, 2026 /PRNewswire/ -- As artificial intelligence reshapes every industry, a critical gap is emerging.
Ohio Valley Banc Gains 16.5% in 6 Months: How to Play the Stock? — Positive
OVBC Zacks Investment Research — January 16, 2026OVBC boosts net interest margin, optimizes balance sheet and leans into relationship-based lending for stability.
Why Is ABM Industries (ABM) Up 3.6% Since Last Earnings Report? — Positive
ABM Zacks Investment Research — January 16, 2026ABM Industries (ABM) reported earnings 30 days ago. What's next for the stock?
Micron (MU) Up 35.4% Since Last Earnings Report: Can It Continue? — Positive
MU Zacks Investment Research — January 16, 2026Micron (MU) reported earnings 30 days ago. What's next for the stock?
Jabil (JBL) Up 16.7% Since Last Earnings Report: Can It Continue? — Positive
JBL Zacks Investment Research — January 16, 2026Jabil (JBL) reported earnings 30 days ago. What's next for the stock?
Via Renewables Announces a Redemption of 232,708 Shares of Its 8.75% Series a Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Stock — Neutral
VIASP Accesswire — January 16, 2026HOUSTON, TX / ACCESS Newswire / January 16, 2026 / Via Renewables, Inc. ("Via Renewables" or the "Company") (NASDAQ:VIASP), an independent retail energy services company, announced today that it will redeem 232,708 shares of its 8.75% Series A Fixed-to-Floating Rate Cumulative Redeemable Perpetual Preferred Stock, par value $0.01 per share (the "Series A Preferred Stock" or the "shares"), at a redemption price equal to $25.00 per share in cash, plus $0.24090 per share of accumulated and unpaid dividends thereon (the "Redemption Price") to, but not including, the redemption date of February 17, 2026 (the "Redemption"). All shares of Series A …
JYD FINAL DEADLINE: ROSEN, A LONGSTANDING LAW FIRM, Encourages Jayud Global Logistics Ltd. Investors to Secure Counsel Before Important January 20 Deadline in Securities Class Action - JYD — Neutral
JYD Newsfile Corp — January 16, 2026New York, New York--(Newsfile Corp. - January 16, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Jayud Global Logistics Ltd. (NASDAQ: JYD) between April 21, 2023 and April 30, 2025, both dates inclusive (the "Class Period"), of the important January 20, 2026 lead plaintiff deadline.
Five Star Bancorp Declares Fourth Quarter Cash Dividend — Neutral
FSBC GlobeNewsWire — January 16, 2026RANCHO CORDOVA, Calif., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Five Star Bancorp (Nasdaq: FSBC) (“Five Star” or the “Company”), a holding company that operates through its wholly owned banking subsidiary, Five Star Bank (the "Bank"), announced today the declaration of a cash dividend of $0.25 per share on the Company's voting common stock.
Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder — Positive
ISRG Seeking Alpha — January 16, 2026Intuitive Surgical continues robust double-digit growth, with Q4 2025 revenues up 19% y/y and strong da Vinci 5 adoption. The firm's 2026 procedure growth guidance of 13–15% disappointed versus expectations, triggering a recent share sell-off despite operational strength. Elevated multiples reflect the company's market dominance, but tactical buying on dips remains warranted for long-term growth investors.
Jade Biosciences, Inc. (JBIO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
JBIO Seeking Alpha — January 16, 2026Jade Biosciences, Inc. (JBIO) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Oculis Holding AG (OCS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript — Neutral
OCS Seeking Alpha — January 16, 2026Oculis Holding AG (OCS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript